.png){kind=logo}
Explore how AI is changing the future of oncology, from early detection to tailored therapies.
.png)
Early detection:
A study published in Nature on breast cancer shows that AI has achieved a 5.7% reduction in false negatives and a 1.2% reduction in false positives in breast cancer detection through mammograms. This allows doctors to identify cancers in earlier stages with greater accuracy.
One of the most significant advantages of this tool is the improvement in diagnosis times. While results used to take days or weeks, AI systems can analyze a large volume of medical images in seconds. This prioritizes patients so doctors can reach faster and more accurate conclusions.
Digital pathology is another area where AI is making significant advances. Using machine learning algorithms, pathologists can analyze large datasets more quickly and accurately. For example, in the United States, Quest Diagnostics uses AI to identify specific biomarkers that can indicate how a patient will respond to a particular treatment. These systems help classify tumors and personalize treatment plans based on the specific characteristics of each patient's cancer, improving accuracy by 20%.
According to several WHO studies, AI is helping to increase the effectiveness of treatments, making them more personalized to the needs of each cancer patient. AI analyzes the genomic profile of a tumor and suggests the most effective therapies for that particular patient. A notable case is IBM's Watson for Oncology algorithm, which has been used in hospitals to recommend personalized treatment plans based on genomic and clinical data. This has resulted in significant improvements in treatment efficacy and a reduction in side effects.
Another critical use of AI in oncology is predicting treatment responses. AI models analyze patient data and predict how they will respond to a particular treatment, allowing doctors to avoid ineffective therapies and minimize side effects. A Mayo Clinic study demonstrated that AI-based predictive models could predict chemotherapy response in breast cancer patients with 80% accuracy.
Drug development:
AI is also accelerating drug development and the identification of new therapeutic targets. Companies like BenevolentAI are using AI to analyze large genomic databases and discover new molecules that could become effective cancer treatments. This approach not only speeds up the drug discovery process but also reduces the costs associated with research and development.
AI-powered virtual assistants and chatbots are emerging as valuable tools for providing continuous support to patients during their treatment. These assistants can offer personalized information, medication reminders, and advice on managing side effects. For example, the Ada Health app uses AI to help patients monitor their symptoms and receive recommendations based on their health data.
Sources:
